1. Introduction {#sec1}
===============

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The name "coronavirus" is derived from the Latin corona, meaning "crown" or "wreath." The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy.

Coronaviruses were first discovered in the 1930s when an acute respiratory infection of domesticated chickens was caused by infectious bronchitis virus (IBV). Later, in the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated \[[@B1]\]. For the first time, human coronaviruses were discovered in the 1960s \[[@B2]\]. The earliest ones studied were from human embryonic tracheal organ cultures obtained from the respiratory tract of an adult with a common cold, which were later named human coronavirus 229E and human coronavirus OC43 \[[@B3]\]. Other human coronaviruses have since been identified, including SARS-CoV in 2003, HCoV NL63 in 2004, HKU1 in 2005, and MERS-CoV in 2012 (\[[@B4]\]). Most of these have involved serious respiratory tract infections.

Recently, a new type of coronaviruses observed in a place called Wuhan city of China, which has a well-known seafood wholesale market, where a large number of people come to sell or buy live seafood. On 31 December 2019, the Wuhan Municipal Health Commission (WMHC) reported a bunch of 27 pneumonia cases of unknown aetiology. Later, on 11 January 2020, the World Health Organization (WHO) named this novel coronavirus as SARS-CoV-2, the virus causing COVID-19, see \[[@B5]\].

The SARS-CoV, MERS-CoV, and COVID-2019 viruses are highly pathogenic Betacoronaviruses and responsible for causing a respiratory and gastrointestinal syndrome. The average incubation period for coronavirus infection is 5 days, with an interval that can reach up to 16 days. The transmissibility of patients infected with SARSCoV is on average 7 days after the onset of symptoms. However, preliminary data from COVID-19 suggests that transmission may occur, even without the appearance of signs and symptoms; see <https://en.wikipedia.org/wiki/Coronavirus_disease_2019>.

2. Detail and Comparison of COVID-19 Cases in the Asian Countries {#sec2}
=================================================================

Asia is one of the most affected region due to COVID-19. In this section, we provide the detailed information and comparison of the total cases, total deaths, total recovered, and active cases in Asian countries. The detail description of the total cases, total deaths, total recovered, and active cases in the Asian countries up to 8th April 2020, are provided in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. For details, we refer to <https://www.worldometers.info/coronavirus/#countries>. Note that the graphical visualization of total cases, total deaths, total recovered, and active cases of the COVID-19 of the Asian countries are displayed in [Appendix A](#secA){ref-type="sec"}. We provide a very simple method for comparison which is not only limited to the Asian countries but it can also be applied for every country to analyze the impact of the disease.

3. Proposed Family of Statistical Models {#sec3}
========================================

In the practice of big data sciences, particularly in statistical theory, there has be an increased interest in defining new statistical models or new families of statistical models to provide a better description of the problems under consideration; see \[[@B6], [@B7]\]. For more details, we refer to \[[@B8]\].

Often, adding extra parameter(s) gives more flexibility to a class of distribution functions, improves the characteristics, and provides better fits to the real-life data than the other modified models. But, unfortunately, on the other hand, the reparametrization problem arises. To avoid such problems and provide a better description of real phenomena of nature, we further carry this branch of statistical theory and propose a new class of statistical models. The proposed class of distributions may be called a new flexible extended-*X* (NFE-*X*) class of distributions.

Let *p*(*t*) be the density of a random variable *T* ∈ \[*a*~1~, *a*~2~\] for −∞≤*a*~1~ \< *a*~2~ \< ∞ and let *K*\[*F*(*x*; *ξ*)\] be a function of *F*(*x*; *ξ*) of a random variable *X*. The cumulative distribution function (cdf) of the T-*X* family of distributions \[[@B9]\] is given by $$\begin{matrix}
{G\left( x \right) = \int_{a_{1}}^{K{\lbrack{F{({x;\xi})}}\rbrack}}p\left( t \right)dt,x \in {\mathbb{R}},} \\
\end{matrix}$$where *K*\[*F*(*x*; *ξ*)\] fulfills some certain conditions, see \[[@B9]\]. The density function corresponding to ([1](#EEq1){ref-type="disp-formula"}) is $$\begin{matrix}
{g\left( x \right) = \left\{ {\frac{\partial}{\partial x}K\left\lbrack {F\left( {x;\xi} \right)} \right\rbrack} \right\} p\left\{ {K\left\lbrack {F\left( {x;\xi} \right)} \right\rbrack} \right\},\quad x \in {\mathbb{R}}.} \\
\end{matrix}$$

If *p*(*t*) = 1 − *e*^−*t*^, *t* ≥ 0, and setting *K*\[*F*(*x*; *ξ*)\] = −log((1 − *F*(*x*; *ξ*)^2^)/(*e*^*F*(*x*;\ *ξ*)^2^^)) in ([1](#EEq1){ref-type="disp-formula"}), we get the cdf of the proposed class of distributions. The random variable *X* is said to have a NFE-*X* class of distributions, if the cumulative distribution function (cdf) of *X*, denoted by *G*(*x*; *ξ*) is given by $$\begin{matrix}
{G\left( {x;\xi} \right) = 1 - \left( \frac{1 - F\left( {x;\xi} \right)^{2}}{e^{F{({x;\xi})}^{2}}} \right),\quad x,\xi \in {\mathbb{R}}.} \\
\end{matrix}$$

The density function corresponding to ([3](#EEq3){ref-type="disp-formula"}) is $$\begin{matrix}
{g\left( {x;\xi} \right) = \frac{2f\left( {x;\xi} \right)F\left( {x;\xi} \right)}{e^{F{({x;\xi})}^{2}}}\left\{ {2 - F\left( {x;\xi} \right)^{2}} \right\},\quad x \in {\mathbb{R}}.} \\
\end{matrix}$$

One of the most prominent motivations of the proposed approach is to introduce a new class of distributions without adding additional parameter results in avoiding rescaling problems. The next section offers, a special submodel of the proposed class called a new flexible extended-Weibull (NFE-Weibull) distribution and investigates the graphical behaviour of its density function.

4. Submodel Description {#sec4}
=======================

This section offers a special submodel of the NFE-*X* class of distributions. Let *F*(*x*; *ξ*) be the distribution function of the Weibull model given by *F*(*x*; *ξ*) = 1 − *e*^−*ηx*^*θ*^^, *x* ≥ 0, *η*, *θ* \> 0, where *ξ* = (*η*, *θ*). Then, the cdf of the NFE-Weibull has the expression given by $$\begin{matrix}
{G\left( {x;\xi} \right) = 1 - \left( \frac{1 - \left( {1 - e^{- \eta x^{\theta}}} \right)^{2}}{e^{{({1 - e^{- \eta x^{\theta}}})}^{2}}} \right),\quad x \geq 0,\eta,\theta > 0,} \\
\end{matrix}$$with density function $$\begin{matrix}
{g\left( {x;\xi} \right) = \frac{2\eta\theta x^{\theta - 1}e^{- \eta x^{\theta}}\left( {1 - e^{- \eta x^{\theta}}} \right)}{e^{{({1 - e^{- \eta x^{\theta}}})}^{2}}}\left( {2 - \left( {1 - e^{- \eta x^{\theta}}} \right)^{2}} \right),\quad x > 0.} \\
\end{matrix}$$

For different values of the model parameters, plots of the density function of the NFE-Weibull model are sketched in [Figure 1](#fig1){ref-type="fig"}.

5. Mathematical Properties {#sec5}
==========================

In this section, some mathematical and statistical properties of the NFE-Weibull distribution derived are discussed.

5.1. Quantile Function {#sec5.1}
----------------------

The quantile function of the NFE-*X* family is the function *Q*(*u*; *ξ*) that satisfies the nonlinear equation $$\begin{matrix}
{Q\left( {G\left( {u;\xi} \right);\xi} \right) = u,\quad u \in \left( {0,1} \right).} \\
\end{matrix}$$

By using ([3](#EEq3){ref-type="disp-formula"}) in ([7](#EEq6){ref-type="disp-formula"}), after some algebraic manipulation, we get $$\begin{matrix}
{Q\left( {G\left( {u;\xi} \right);\xi} \right) = G^{- 1}\left( u \right) = F^{- 1}\left( u \right),} \\
\end{matrix}$$where *t* is the solution of log(1 − *u*) + *F*(*x*; *ξ*)^2^ − log(1 − *F*(*x*; *ξ*)^2^).

5.2. Moments {#sec5.2}
------------

Here, we derive some of the moments for the NFE-*X* family. For the sake of simplicity we omit the dependency of *g*(*x*; *ξ*) and *G*(*x*; *ξ*) on the parameter vector *ξ*. The density ([4](#EEq4){ref-type="disp-formula"}) can be represented as follows: $$\begin{matrix}
{g\left( x \right) = 2\frac{f\left( {x;\xi} \right)F\left( {x;\xi} \right)}{e^{F{({x;\xi})}^{2}}}\left\{ {2 - F\left( {x;\xi} \right)^{2}} \right\},} \\
{g\left( x \right) = \sum\limits_{i = 0}^{1}\left( {- 1} \right)^{i}2^{({{({4 - i})}/2})}\begin{pmatrix}
1 \\
i \\
\end{pmatrix}\frac{f\left( {x;\xi} \right)F\left( {x;\xi} \right)^{2i + 1}}{e^{F{({x;\xi})}^{\theta}}},} \\
{g\left( x \right) = \sum\limits_{i = 0}^{1}\sum\limits_{j = 0}^{\infty}\frac{\left( {- 1} \right)^{({i + j})}2^{({{({4 - i})}/2})}}{j!}\begin{pmatrix}
1 \\
i \\
\end{pmatrix}f\left( {x;\xi} \right)F\left( {x;\xi} \right)^{2{({i + j})} + 1},} \\
\end{matrix}$$

Using the pdf and cdf of the Weibull distribution in ([9](#EEq8){ref-type="disp-formula"}), we get $$\begin{matrix}
{g\left( x \right) = \sum\limits_{i = 0}^{1}\sum\limits_{j = 0}^{\infty}\sum\limits_{k = 0}^{2{({i + j})} + 1}\frac{\left( {- 1} \right)^{({i + j + k})}2^{({{({4 - i})}/2})}}{j!}\begin{pmatrix}
1 \\
i \\
\end{pmatrix}\begin{pmatrix}
{2\left( {i + j} \right) + 1} \\
k \\
\end{pmatrix}\tau_{k,\eta,\theta},} \\
\end{matrix}$$where *τ*~*k*,*η*,*θ*~ = *ηθx*^*θ*−1^*e*^−*η*(*k*\ +\ 1)*x*^*θ*^^. For any positive integer *r*, the *r*^th^ moment of the NFE-Weibull distribution is given by $$\begin{matrix}
{\mu_{r}^{\prime} = E\left( X^{r} \right) = \int_{0}^{\infty}x^{r}g\left( x \right)dx.} \\
\end{matrix}$$

On using ([10](#EEq9){ref-type="disp-formula"}) in ([11](#EEq10){ref-type="disp-formula"}), we get the *r*^th^ moment of the NFE-Weibull distribution.

For *r* = 1, 2, 3, 4 we get the first four moments of the NFE-*X* distributions. The effects of the shape parameters on the skewness and kurtosis can be detected on the moments. Based on moments, we obtain skewness and kurtosis measures of the NFE-Weibull distribution. The skewness of the NFE-Weibull distribution is obtained as using the following expression: $$\begin{matrix}
{\text{Skewness} = \frac{\mu_{3}}{\mu_{2}^{3/2}},} \\
\end{matrix}$$where *μ*~2~ and *μ*~3~ are the second and third moments of the random variable *X* with pdf ([6](#EEq5){ref-type="disp-formula"}). Furthermore, the kurtosis of *X* is derived as $$\begin{matrix}
{\text{Kurtosis} = \frac{\mu_{4}}{\mu_{2}^{2}},} \\
\end{matrix}$$where *μ*~4~ is the fourth moment of *X*. These measures are less sensitive to outliers. Plots for the mean, variance, skewness, and kurtosis of the NFE-Weibull distribution are displayed in Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}.

5.3. On Other Means and Moments {#sec5.3}
-------------------------------

With *t* \> 0, the following result proposes an expansion of the primitive $$\begin{matrix}
{\int_{0}^{t}x^{r}g\left( x \right)dx = \sum\limits_{i = 0}^{1}\sum\limits_{j = 0}^{\infty}\sum\limits_{k = 0}^{2{({i + j})} + 1}\frac{\left( {- 1} \right)^{({i + j + k})}2^{({{({4 - i})}/2})}}{j!}\begin{pmatrix}
1 \\
i \\
\end{pmatrix}\begin{pmatrix}
{2\left( {i + j} \right) + 1} \\
k \\
\end{pmatrix}\tau_{r,k,\eta,\theta},} \\
\end{matrix}$$where *τ*~*r*,*k*,*η*,*θ*~ = ∫~0~^*t*^*ηθx*^*r*+*θ*−1^*e*^−*η*(*k*\ +\ 1)*x*^*θ*^^.

Several crucial conditional moments can be obtained using the integral ∫~0~^*t*^*x*^*r*^*g*(*x*)*dx* for various values of *r*. The most useful of them are presented below. For any *t* \> 0, (i)The *r*^th^ conditional moments of *X* is given by, $$\begin{matrix}
{E\left( {X^{r}\, \mid \, X > t} \right) = \frac{1}{1 - G\left( t \right)}\int_{t}^{+ \infty}x^{r}g\left( x \right)dx = \frac{1}{1 - G\left( t \right)}\left( {E\left( X^{r} \right) + \int_{0}^{t}x^{r}g\left( x \right)dx} \right)} \\
\end{matrix}$$(ii)The *r*^th^ reversed moments of *X* is given by $$\begin{matrix}
{E\left( {X^{r}\, \mid \, X \leq t} \right) = \frac{1}{G\left( t \right)}\int_{0}^{t}x^{r}g\left( x \right)dx} \\
\end{matrix}$$(iii)The mean deviations of *X* about the mean, say *μ* is given by $$\begin{matrix}
{\delta = E\left( \left| {X - \mu} \right| \right) = 2\mu G\left( \mu \right) - 2\int_{0}^{\mu}xg\left( x \right)dx} \\
\end{matrix}$$where *μ* = *E*(*X*).(iv)The mean deviations of *X* about the median, say *M* is given by $$\begin{matrix}
{\tau = E\left( \left| {X - M} \right| \right) = \mu - 2\int_{0}^{M}xg\left( x \right)dx} \\
\end{matrix}$$ The residual life parameters can be also determined using *E*(*X*^*r*^) and ∫~0~^*t*^*x*^*r*^*g*(*x*; *θ*, *η*)*dx* for several values of *r*. In particular,(v)The mean residual life is defined as $$\begin{matrix}
{K\left( t \right) = E\left( {X - t\, \mid \, X > t} \right) = \frac{1}{S\left( t \right)}\left( {E\left( X \right) - \int_{0}^{t}xg\left( x \right)dx} \right) - t} \\
\end{matrix}$$and the variance residual life is given by $$\begin{matrix}
{V\left( t \right) = Var\left( {X - t\, \mid \, X > t} \right) = \frac{1}{S\left( t \right)}\left( {E\left( X^{2} \right) - \int_{0}^{t}x^{2}g\left( x \right)dx} \right) - t^{2} - 2tK\left( t \right) - \left\lbrack {K\left( t \right)} \right\rbrack^{2}} \\
\end{matrix}$$(vi)The mean reversed residual life is defined as $$\begin{matrix}
{L\left( t \right) = E\left( {t - X\, \mid \, X \leq t} \right) = t - \frac{1}{G\left( t \right)}\int_{0}^{t}xg\left( x \right)dx} \\
\end{matrix}$$and the variance reversed residual life is defined as $$\begin{matrix}
{W\left( t \right) = Var\left( {t - X\, \mid \, X \leq t} \right) = \frac{1}{G\left( t \right)}\int_{0}^{t}x^{2}g\left( x \right)dx + 2tL\left( t \right) - \left\lbrack {L\left( t \right)} \right\rbrack^{2} - t^{2}} \\
\end{matrix}$$

6. Maximum Likelihood Estimation and Monte Carlo Simulation {#sec6}
===========================================================

The section deals with the estimation of the model parameters and Monte Carlo simulation to assess the performance of the estimators.

6.1. Maximum Likelihood Estimation {#sec6.1}
----------------------------------

The maximum likelihood estimation procedure is the commonly employed method of estimating the model parameters. The estimators that are obtained based on this procedure enjoy desirable asymptotic properties, and therefore, they are often utilized to obtain confidence intervals (CI) and test of statistical hypotheses. Suppose that *x*~1~, *x*~2~, ⋯, *x*~*n*~ be the observed values of a random sample of size *n* obtained from ([4](#EEq4){ref-type="disp-formula"}). The corresponding log-likelihood function can be expressed as $$\begin{matrix}
{\ell\left( \xi \right) = n\log 2 + \sum\limits_{i = 0}^{n}\log f\left( {x_{i};\xi} \right) + \sum\limits_{i = 0}^{n}\log F\left( {x_{i};\xi} \right) - \sum\limits_{i = 0}^{n}F\left( {x_{i};\xi} \right)^{2} + \sum\limits_{i = 0}^{n}\log\left\lbrack {2 - F\left( {x_{i};\xi} \right)^{2}} \right\rbrack.} \\
\end{matrix}$$

The log-likelihood function can be maximized either directly or by solving the nonlinear likelihood function obtained by differentiating. The first-order partial derivative of the log-likelihood function with respect to *ξ* is given by $$\begin{matrix}
{\frac{\partial}{\partial\xi}\ell\left( \xi \right) = \sum\limits_{i = 0}^{n}\frac{\partial f\left( {x_{i};\xi} \right)/\partial\xi}{f\left( {x_{i};\xi} \right)} + \sum\limits_{i = 0}^{n}\frac{\partial F\left( {x_{i};\xi} \right)/\partial\xi}{F\left( {x_{i};\xi} \right)} - 2\sum\limits_{i = 0}^{n}\frac{F\left( {x_{i};\xi} \right)\partial F\left( {x_{i};\xi} \right)}{\partial\xi} - 2\sum\limits_{i = 0}^{n}\frac{F\left( {x_{i};\xi} \right)\partial F\left( {x_{i};\xi} \right)/\partial\xi}{2 - F\left( {x_{i};\xi} \right)^{2}}.} \\
\end{matrix}$$

Setting (*∂*/*∂ξ*)*ℓ*(*ξ*) equal to zero and solving numerically yields the maximum likelihood estimators (MLEs) of *ξ* = (*θ*, *η*). An optimization software such as the R function *optim* or *nlminb* can be used to find $\hat{\mathbf{\xi}}$ that minimizes the negative log-likelihood function (i.e., maximizes the log-likelihood function). Although the specification of the derivatives is optional in these R functions, fast and rapid convergence may be achieved if the expressions for the negative log-likelihood function are provided. In our implementation (R codes are given in [Appendix B](#secB){ref-type="sec"}), we use optim() R-function with the argument method = "SANN" to obtain the MLEs.

6.2. Monte Carlo Simulation {#sec6.2}
---------------------------

A numerical investigation is established to examine the behaviour of MLEs for the NFE-Weibull model. For different sample sizes, measures like biases, absolute biases, and mean square errors (MSEs) are calculated to evaluate the performance of the estimators. We generate 500 from NFE-Weibull distribution of sizes; *n* = 25, 50, ⋯, 500An optimization algorithm requires a set of initial values for the parameters. Certain values of the model parameters (*θ*, *η*) are chosen as Set 1 : *θ* = 0.5, *η* = 1; Set 2 : *θ* = 1.2, *η* = 1; and Set 3 : *θ* = 0.8, *η* = 1.2MLEs of the parameters *θ* and *η* are calculated for each *n* and for all setsCalculate the biases, absolute biases, and MSE for each *n*

The simulation results are displayed in Figures [4](#fig4){ref-type="fig"}[](#fig5){ref-type="fig"}--[6](#fig6){ref-type="fig"}.

7. Modeling COVID-19 Total Deaths of the Asian Countries {#sec7}
========================================================

We mentioned earlier that a broad statistical analysis of the events that occurred due to COVID-19 is still to come. But, now it is immediately needed to propose a suitable model to provide a better description of the COVID-19 total death data to estimate the required number of places in hospitals, the level of individual protection, the rate of isolation of infected persons, etc. In this section, we model the COVID-19 total deaths that have occurred in the Asian countries up to April 8, 2020. The NFE-Weibull distribution applied to this dataset in comparison with the other well-known distributions such as the two-parameter Weibull, three-parameter Marshall-Olkin Weibull (MOW), and exponentiated Weibull (EW) distributions. It is important to emphasize that the EW distribution is a popular model for analyzing data in the applied areas, particularly in medical sciences, see \[[@B10]\]. The MOW distribution is another nonnested model and offers the characteristics of the Weibull and gamma distributions, see \[[@B11]\]. The cdfs of the competing distributions are as follows: (1)Weibull distribution $$\begin{matrix}
{G\left( {x;\theta,\eta} \right) = 1 - e^{- \eta x^{\theta}},\quad x \geq 0,\theta,\eta > 0} \\
\end{matrix}$$(2)EW distribution $$\begin{matrix}
{G\left( {x;a,\theta,\eta} \right) = \left( {1 - e^{- \eta x^{\theta}}} \right)^{a},\quad x \geq 0,a,\theta,\eta > 0} \\
\end{matrix}$$(3)MOW distribution $$\begin{matrix}
{G\left( {x;\theta,\eta,\sigma} \right) = \frac{1 - e^{- \eta x^{\theta}}}{1 - \left( {1 - \sigma} \right)\left( {1 - e^{- \eta x^{\theta}}} \right)},\quad x \geq 0,\theta,\eta,\sigma > 0} \\
\end{matrix}$$

Selection of an appropriate approximation model is desirable to assign some preference to the alternatives. Therefore, we consider certain analytical measures in order to verify which distribution fits better the considered data. These analytical measures include (i) four discrimination measures such as the Akaike information criterion (AIC), Bayesian information criterion (BIC), Hannan-Quinn information criterion (HQIC), and consistent Akaike information criterion (CAIC) and (ii) three other goodness-of-fit measures including the Anderson Darling (AD) test statistic, Cramer-Von-Messes (CM) test statistic, and Kolmogorov-Smirnov (KS) test statistics with corresponding *p* values. A model with lowest values for these statistics is considered a best candidate model. The formulae for these measures can be explored in \[[@B12]\]

For the COVID-19 total death data of the Asian countries, the estimates with the standard error (in parentheses) of the model parameters are provided in [Table 3](#tab3){ref-type="table"}. The analytical measures of the NFE-Weibull and other considered models are provided in Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}.

As we see, the results (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}) show that the NFE-Weibull distribution has smaller values of the analytical measures and the maximum *p* value reveals that the proposed model provides better fit than the other considered competitors. Hence, the proposed model can be used as a best candidate model for modeling the COVID-19 total death data of the Asian countries. In support of the results provided in Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}, the estimated cdfs of the fitted distributions are plotted in [Figure 7](#fig7){ref-type="fig"}, whereas the Kaplan-Meier survival plots of the proposed and other fitted distributions are presented in [Figure 8](#fig8){ref-type="fig"}. From Figures [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}, it is clear that the proposed model fit the estimated cdf and survival function very closely than the other competitors.

8. Concluding Remarks {#sec8}
=====================

The COVID-19 is one among the most deadly viruses that has greatly affected daily life affairs. The government and a number of other organizations should be interested to provide bases for comparison and to provide a better description of the data under consideration to get reliable estimates of the parameters of interest. In this article, a brief comparison of the COVID-19 events such as total cases, total deaths, total recovered, and active cases of the Asian countries are provided. Such clear cut comparison should be helpful to facilitate the COVID-19 affected peoples. Furthermore, a new class of statistical models is introduced. Some mathematical properties of the proposed class are derived. The maximum likelihood estimators of the model parameters are obtained. Finally, a special submodel of the proposed class called a new flexible extended Weibull distribution is studied in detail. The flexibility provided by the proposed model could be very useful in adequately describing the total death data in the Asian countries due to the COVID-19. We observed that the proposed model may provide a close fit to the COVID-19 total death data.

The first author also acknowledge the support of the Shandong Province Social Science Planning Research Project: Research on Attraction of Charitable Organizations under the Background of Social Governance Innovation (ProjectNo. 19CSHJ07)

A. Display of the COVID-19 Events {#secA}
=================================

Figures [9](#fig9){ref-type="fig"}[](#fig10){ref-type="fig"}[](#fig11){ref-type="fig"}--[12](#fig12){ref-type="fig"} offers the graphical display of the COVID-19 events that have taken place in the Asian Countries.

Note: Since the total deaths for the BT, KH, LA, MO, MV, MN, NP, TL, and VN are zero "0". Therefore, the plotting of the total deaths for these countries are omitted.

B. R Codes {#secB}
==========

B.1. R Code for Analysis {#secB.1}
------------------------

The following code has been used to calculate the values of the model parameters.

Note: Here, pm is used for proposed model.

library(AdequacyModel)

data=c(14,9,8,5,20,1,3333,9,4,178,240,3993,69,72,93,6,7,1,4, 19,65,3,2,60,182,6,41,6,200,7,1,2,5,30,812,12,3)

sort(data)

data

\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# PDF of the proposed model

pdf_pm \<- function(par,x)

{

theta=par\[1\] eta=par\[2\] theta∗2∗eta∗(x\^(theta-1))∗exp(-eta∗x\^theta)∗((1-exp(-eta∗x\^theta))) ∗(2-((1-exp(-eta∗x\^theta))\^2))∗(1/(exp((1-exp(-eta∗x\^theta))\^2)))

}

\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\#\# CDF of the proposed model

cdf_pm \<- function(par,x)

{

theta=par\[1\]

eta=par\[2\]

1-((1-((1-exp(-eta∗x\^theta))\^2))/(exp((1-exp(-eta∗x\^theta))\^2)))

}

set.seed(0)

goodness.fit(pdf=pdf_pm, cdf=cdf_pm, starts = c(1,1), data = data, method=\"SANN\", domain=c(0,Inf),mle=NULL)

B.2. R Code for Plotting the Estimated Distribution Function. {#secB.2}
-------------------------------------------------------------

x=c(14,9,8,5,20,1,3333,9,4,178,240,3993,69,72,93,6,7,1,4, 19,65,3,2,60,182,6,41,6,200,7,1,2,5,30,812,12,3)

sort(x) x

\#NAPTW

theta=0.3147927

eta=0.2818076

x\<-sort(x)

F1\<-ecdf(x)

ecdf\<-F1(c(x)) proposedcdf\<-1-((1-((1-exp(-eta∗x\^theta))\^2))/(exp((1-exp(-eta∗x\^theta))\^2))) plot(x,ecdf,lty=1,lwd=4,type=\"s\",xlab=\"x\",ylab=\"G(x; 0.3147927, 0.2818076)\", ylim=c(0,1),xlim=c(min(x),max(x)),col=\"black\")

par(new=TRUE)

plot(x,proposedcdf,xlab=\"x\",ylab=\"G(x; 0.3147927, 0.2818076)\", ylim=c(0,1),xlim=c(min(x),max(x)),col=\"red\",lty =5, lwd=4,type=\"l\")

par(new=TRUE)

legend(1500, 0.4,c(\"Real Data\",\"Proposed Model\"),col=c(1,2), lty =c(1,5), bty=\"n\", cex=1.2)

B.3. R Code for Plotting the Fitted Survival Function. {#secB.3}
------------------------------------------------------

x=c(14,9,8,5,20,1,3333,9,4,178,240,3993,69,72,93,6,7,1,4, 19,65,3,2,60,182,6,41,6,200,7,1,2,5,30,812,12,3)

summary(x)

library(survival)

delta=rep(1,length(x))

x\<-sort(x)

km = survfit(Surv(x,delta)\~1)

plot(km,conf.int=FALSE,ylab=\"S(x; 0.3147927, 0.2818076)\",xlab=\"x\", lty =1, col=\"black\",pch=19,lwd=4)

theta=0.3147927

eta=0.2818076

ss \<- function(x)

{

((1-((1-exp(-eta∗x\^theta))\^2))/(exp((1-exp(-eta∗x\^theta))\^2)))

}

lines(seq(1, 3993,length.out =100),ss(seq(1,3993,length.out =100)), col=\"red\",lty =5,lwd=4) legend(1500, 0.7,c(\"Real Data\",\"Proposed Model\"),col=c(1,2), lty =c(1,5), bty=\"n\", cex=1.2)
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=================

The data used to support the findings of this study are included within the article.
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###### 

Detailed report and comparison of COVID-19 cases in the Asian countries.

  Countries           Total cases   Total deaths   Total recovered   Active cases
  ------------------- ------------- -------------- ----------------- --------------
  Afghanistan (AF)    444           14             29                401
  Azerbaijan (AZ)     822           8              63                751
  Bahrain (BH)        821           5              467               349
  Bangladesh (BD)     218           20             33                165
  Bhutan (BT)         5             0              2                 3
  Brunei (BN)         135           1              91                43
  Cambodia (KH)       117           0              63                54
  China (CN)          81802         3333           77279             1190
  Cyprus (CY)         526           9              52                465
  Hong Kong (HG)      961           4              264               693
  India (IN)          5749          178            506               5065
  Indonesia (ID)      2956          240            222               2494
  Iran (IR)           64586         3993           29812             30781
  Iraq (IQ)           1202          69             452               681
  Israel (IL)         9409          72             801               8531
  Japan (JP)          4257          93             622               3542
  Jordan (JO)         358           6              150               202
  Kazakhstan (KZ)     718           7              54                657
  Kuwait (KW)         855           1              111               743
  Kyrgyzstan (KG)     270           4              33                233
  Laos (LA)           15            0              0                 15
  Lebanon (LB)        575           19             62                494
  Macao (MO)          45            0              10                35
  Malaysia (MY)       4119          65             1487              2567
  Maldives (MV)       19            0              13                6
  Mongolia (MN)       16            0              4                 12
  Myanmar (MM)        22            3              0                 19
  Nepal (NP)          9             0              1                 8
  Oman (OM)           419           2              72                345
  Pakistan (PK)       4196          60             467               3669
  Philippines (PH)    3870          182            96                3592
  Qatar (QA)          2210          6              178               2026
  Saudi Arabia (SA)   3122          41             631               2450

###### 

Detailed report and comparison of COVID-19 cases in the Asian countries.

  Countries                   Total cases   Total deaths   Total recovered   Active cases
  --------------------------- ------------- -------------- ----------------- --------------
  Singapore (SG)              1623          6              406               1211
  South Korea (SK)            10384         200            6776              3408
  Sri Lanka (LK)              189           7              44                138
  Palestine (PS)              263           1              44                218
  Syria (SY)                  19            2              3                 14
  Taiwan (TW)                 379           5              67                307
  Thailand (TH)               2369          30             888               1451
  Timor-Leste (TL)            1             0              0                 1
  Turkey (TR)                 38226         812            1846              35568
  United Arab Emirates (AE)   2659          12             239               2408
  Uzbekistan (UZ)             545           3              30                512
  Vietnam (VN)                251           0              126               125

###### 

Estimated parameters along with standard errors (in parenthesis) of the fitted models.

  Distribution   *θ*              *η*              *a*              *σ*
  -------------- ---------------- ---------------- ---------------- ----------------
  NFE-Weibull    0.314 (0.0392)   0.281 (0.0567)                    
  Weibull        0.424 (0.0484)   0.178 (0.5544)                    
  MOW            0.660 (0.0442)   0.014 (0.4690)                    0.113 (1.8756)
  EW             0.173 (0.0323)   1.794 (0.5113)   13.375 (7.858)   

###### 

Discrimination measures of the NFE-Weibull model and other competing models.

  Distribution   AIC       BIC       CAIC      HQIC
  -------------- --------- --------- --------- ---------
  NFE-Weibull    386.178   389.400   386.531   387.314
  Weibull        394.615   397.837   394.968   395.751
  MOW            389.535   392.367   388.262   389.238
  EW             392.503   395.336   392.231   393.207

###### 

Goodness-of-fit measures of the NFE-Weibull model and other competing models.

  Distribution   CM      AD      KS      *p* value
  -------------- ------- ------- ------- -----------
  NFE-Weibull    0.188   1.165   0.152   0.353
  Weibull        0.284   1.786   0.193   0.276
  MOW            0.209   1.206   0.171   0.329
  EW             0.232   1.499   0.186   0.303

[^1]: Academic Editor: Po-Hsiang Tsui
